Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
Well, yes, the sad reality is that very many people are rather stupid. This won’t change and we should treat it as a fact - people are always going to fall for schemes. I think the fact that they’re stupid doesn’t mean they deserve to be exploited, though. This is a failure of laws and regulations.
Agreed. And basically that is exactly what I said.